Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the safety, effectiveness and anti-microbial
effects of Arestin (minocycline HCl) 1 mg Microspheres in the treatment of subjects with
peri-implantitis, when used in combination with mechanical debridement.
The hypothesis of the study is that Arestin in combination with mechanical debridement is
more effective in the treatment of peri-implantitis when compared to mechanical debridement
alone. The primary efficacy measure will be the reduction of probing depth at Day 180 as
measured at qualifying implant sites.